63 related articles for article (PubMed ID: 2802934)
1. [The immune resistance of patients with colorectal cancer].
Nagy A
Arch Geschwulstforsch; 1989; 59(4):265-70. PubMed ID: 2802934
[TBL] [Abstract][Full Text] [Related]
2. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
[TBL] [Abstract][Full Text] [Related]
3. [Changes in nutritional status and immune function in patients with colorectal cancer after operation].
Ma T; Yao XQ; Lin F; Zhong SZ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):76-8. PubMed ID: 15684004
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy in radical surgery of colorectal carcinoma].
Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A
Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635
[TBL] [Abstract][Full Text] [Related]
5. A descriptive study of immune status in patients undergoing colorectal surgery: lymphocyte phenotypes.
Tax AW; Orsi AJ; Lafferty M; Barsevick A; Luborsky L; Prystowsky M; Nahass D; Lowery B; McCorkle R
Oncol Nurs Forum; 1994 Oct; 21(9):1539-44. PubMed ID: 7816679
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors affecting the survival of operated patients with colorectal cancer: significance of delayed hypersensitivity skin reactions and nutritional status.
Triantafillidis JK; Papatheodorou K; Kogevinas M; Manoussakis K; Nicolakis D
Ital J Gastroenterol; 1995; 27(8):419-24. PubMed ID: 8775467
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for colorectal cancer: effects on nutritional intervention.
Planas M; Peñalva A; Burgos R; Puiggrós C; Pérez-Portabella C; Espín E; Armengol M; Rosselló J
Clin Nutr; 2007 Dec; 26(6):691-7. PubMed ID: 18029063
[TBL] [Abstract][Full Text] [Related]
8. Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer.
Rains N; Cannan RJ; Chen W; Stubbs RS
Hepatogastroenterology; 2001; 48(38):347-51. PubMed ID: 11379307
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of immunodeficiency and postoperative infective complications in patients undergoing surgical resection for carcinoma of the colon-rectum. Clinical study on 50 cases, using thymus hormones and thymopentin in particular].
Elia P; Lombardo G; Delpiano C; Granello M
Minerva Chir; 1994 Jun; 49(6):575-80. PubMed ID: 7970063
[TBL] [Abstract][Full Text] [Related]
10. Early assessment of nutritional status in patients scheduled for colorectal cancer surgery.
Karlsson S; Andersson L; Berglund B
Gastroenterol Nurs; 2009; 32(4):265-70. PubMed ID: 19696603
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous delayed hypersensitivity in patients with colorectal cancer: application of multi-test.
Papatheodorou K; Triantafillidis JK; Kogevinas M; Manoussakis K; Nicolakis D; Merikas E
Ital J Gastroenterol; 1994; 26(1):12-5. PubMed ID: 8025300
[TBL] [Abstract][Full Text] [Related]
12. Host response to colorectal cancer.
Salama P; Platell C
ANZ J Surg; 2008 Sep; 78(9):745-53. PubMed ID: 18844901
[TBL] [Abstract][Full Text] [Related]
13. Immunostimulation by propionibacteria--effects on immune status and antineoplastic treatment.
Isenberg J; Stoffel B; Wolters U; Beuth J; Stützer H; Ko HL; Pichlmaier H
Anticancer Res; 1995; 15(5B):2363-8. PubMed ID: 8572653
[TBL] [Abstract][Full Text] [Related]
14. Antiviral cellular immunity in colorectal cancer patients.
Kiewe P; Wojtke S; Thiel E; Nagorsen D
Hum Immunol; 2009 Feb; 70(2):85-8. PubMed ID: 19133306
[TBL] [Abstract][Full Text] [Related]
15. [Relations between markers and immunological status in surgical patients. Tumor markers and immunity in surgery].
Nano M; Ricci E; Pecchio F; Rapellino M; Giaccone M; Molaschi M
Minerva Med; 1988 Nov; 79(11):943-6. PubMed ID: 3200471
[TBL] [Abstract][Full Text] [Related]
16. Cellular and humoral inflammatory response after laparoscopic and conventional colorectal resections.
Ordemann J; Jacobi CA; Schwenk W; Stösslein R; Müller JM
Surg Endosc; 2001 Jun; 15(6):600-8. PubMed ID: 11591950
[TBL] [Abstract][Full Text] [Related]
17. Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support.
Bozzetti F; Gianotti L; Braga M; Di Carlo V; Mariani L
Clin Nutr; 2007 Dec; 26(6):698-709. PubMed ID: 17683831
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial.
Harrop R; Connolly N; Redchenko I; Valle J; Saunders M; Ryan MG; Myers KA; Drury N; Kingsman SM; Hawkins RE; Carroll MW
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3416-24. PubMed ID: 16740766
[TBL] [Abstract][Full Text] [Related]
19. Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study.
Kapoor S; Pal S; Sahni P; Dattagupta S; Kanti Chattopadhyay T
J Surg Res; 2005 Dec; 129(2):172-5. PubMed ID: 15882879
[TBL] [Abstract][Full Text] [Related]
20. A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.
Ullenhag GJ; Spendlove I; Watson NF; Indar AA; Dube M; Robins RA; Maxwell-Armstrong C; Scholefield JH; Durrant LG
Clin Cancer Res; 2006 Dec; 12(24):7389-96. PubMed ID: 17121873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
